NanoMarkets LC, a leading industry
consultancy based here, today announced the release of two White Papers that
forecast and analyze the role of nanotechnology in drug discovery and drug
delivery. The papers are available for immediate download from the firm's web
site, http://www.nanomarkets.net.
About the Papers:
In the first paper, "Nano-Enabled Drug Discovery: Seven Technologies to
Watch," NanoMarkets examines the impact that a range of new nanotechnologies
will have on the drug discovery process. Technologies discussed in this paper
include Atomic Force Microscopy, Near-field Scanning Optical Microscopes,
Surface Plasmon Resonance, Nano Mass Spectrometry, Dip-pen Nanolithography,
Nano-Arrays and Quantum Dots.
The new White Paper shows how these technologies will lead to important
improvements in drug discovery. Among the improvements that NanoMarkets
expects to see are:
- Better imaging (including real-time imaging), providing researchers
with a deeper understanding of how biological processes are affected by
a new compound.
- More sensitive fundamental research techniques for drug discovery
applications using of dip pen technology.
- Major improvements in today's microarray and fluorescent dye
technologies.
NanoMarkets believes that all of these improvements will be highly valued
in a drug industry that is finding it harder to produce new drugs -- and
especially new blockbuster drugs. It is increasingly seeking new drug
discovery technologies that can improve R&D success rates and time to market.
NanoMarkets therefore believes that these improvements are likely to lead to
substantial new business revenues over the next few years.
In "Six Opportunities in Nano-Enabled Drug Delivery Systems," NanoMarkets
examines six types of drug delivery systems in which nanotechnology is likely
to have an impact: Injectable delivery systems, Implantable delivery systems,
Oral delivery systems Topical Delivery Systems, Transdermal Systems, and Toxin
Removal. As this list suggests, nanotechnological improvements promise to
impact almost every common mode of drug delivery, and nano-enabled drug
delivery is likely to be broadly felt:
- Improvements from these systems will include lower drug toxicity,
lowering cost of treatments, improved bioavailability and extension of
the economic life of proprietary drugs
- Nano-enabled drug delivery will provide improvements in the treatment
of some of the most widespread diseases, such as cancer and diabetes.
NanoMarkets believes that not only will the nano-enabled drug delivery
market be one of the first true nanomedicine markets to evolve, but that
significant revenue opportunities for participants will be created.
